Canakinumab Subcutaneous and Jivi Intravenous
Determining the interaction of Canakinumab Subcutaneous and Jivi Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: Jivi
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Jolessa
- Canakinumab Subcutaneous-Jolessa extended-cycle
- Canakinumab Subcutaneous-Jolivette
- Canakinumab Subcutaneous-Jornay PM
- Canakinumab Subcutaneous-Juleber
- Canakinumab Subcutaneous-Juluca
- Jivi Intravenous-Canasa
- Jivi Intravenous-Canasa Pac rectal
- Jivi Intravenous-Canasa rectal
- Jivi Intravenous-Cancidas
- Jivi Intravenous-Candesartan
- Jivi Intravenous-Candesartan and Hydrochlorothiazide